People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later

In a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10% of their body weight after four years. An earlier analysis of data from this trial found that semaglutide reduced the risk of heart attack, stroke and cardiovascular death in people with obesity or who are overweight.
Healthline Multiple Sclerosis
May 16, 2024
People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later
 
READ ON
→
How Miss America Madison Marsh Is Working to Improve Cancer Care
 
READ ON
→
Dietitians' Picks of the 5 Best Weight Loss Programs in 2024
 
READ ON
→
How to Tell It's Time to Switch Treatment for Your Severe Eczema
 
READ ON
→
MORE STORIES
RESOURCE FOR YOU
 
 
 
HEALTHLINE RESOURCE
 
What we're reading next
Is There a Best Time to Tan Outside in the Sun?
How to Avoid a Migraine Attack Before It Happens
The Link Between Ulcerative Colitis and Osteoporosis, Plus Tips for Prevention
Self-Administered Gerocognitive Exam (SAGE) for Dementia
Advertisement
 
healthline
FB   Tiktok   TW   youtube   INSTA

No comments:

Post a Comment